Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”

Time series comparing trends at HSJ and control hospitals in the pre-intervention and intervention period. Significance test determine if trends differ between groups. by Eva Rydahl (6260771)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Increase in physical activity (100 step, 500 steps or 1000 steps) after the challenge according to decrease in screen time < or ≥60 minutes. by Annaëlle Le Steunf (19838110)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

“…Additionally, the plots on the right side display the average plaque count across the cohorts. …”

The influence of the controlled pH conditions at the sample preparation step on the obtained signals (panel A: extraction using a mixture of MeOH and EtOH; panel B: extraction usin... by Ewa Paszkowska (21246702)

Subjects:

Fig 1 - by Farshid Maleki (20521649)

Subjects:

Fig 8 - by Farshid Maleki (20521649)

Subjects:

Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. by Farshid Maleki (20521649)

Subjects:

Fig 4 - by Farshid Maleki (20521649)

Subjects:

Fig 9 - by Farshid Maleki (20521649)

Subjects:

Trypan blue dye exclusion assay for cell viability evaluation (% of control). by Farshid Maleki (20521649)

Subjects:

Fig 7 - by Farshid Maleki (20521649)

Subjects:

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

Fig 10 - by Farshid Maleki (20521649)

Subjects:

Fig 5 - by Farshid Maleki (20521649)

Subjects:

Fig 6 - by Farshid Maleki (20521649)

Subjects:

Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

Stepped-Wedge Trial Diagram. by Sugy Choi (800862)

“…This report specifically focuses on Project 3, which involves a stepped-wedge trial with 35 clinics receiving a quality management intervention that includes performance coaching. …”

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)